Vickery Stephen B, Burch Andrew D, Vickery P Brittany
PharmD Student, Wingate University School of Pharmacy, Hendersonville, North Carolina.
Associate Professor, Wingate University School of Pharmacy, Hendersonville, North Carolina.
Ment Health Clin. 2022 Jun 10;12(3):205-209. doi: 10.9740/mhc.2022.06.205. eCollection 2022 Jun.
Nitrofurantoin (NIT) is a commonly utilized antibiotic for the treatment of UTIs. Although well tolerated, NIT is not without potential adverse reactions. This case report details the observation of probable NIT-induced drug fever in a patient receiving clozapine. A 61-year-old female with treatment-refractory schizoaffective disorder was admitted to a psychiatric unit with paranoia and auditory hallucinations, prompting clozapine initiation during day 1 of hospitalization. Due to worsening hallucinations and anxiety, antibiotic therapy with NIT for a presumed UTI was initiated 8 days after admission. Febrile episodes were observed beginning on hospital day (HD) 9, leading to concern for possible neuroleptic malignant syndrome (NMS), which led to clozapine discontinuation. The patient received a total of 3 doses of NIT with continued fever until discontinuation on HD 10. No further complications were encountered, and clozapine was safely resumed on HD 13. Although sparsely described in the medical literature, occurrences of drug fever attributable to NIT are previously reported. A review of the medical literature identified only 5 previously published articles specific to NIT-induced drug fever, none of which specified interruptions of psychotropic therapy for a patient with acute psychiatric decompensation. This case highlights the differential diagnosis of fever related to NIT in a patient receiving clozapine when NMS was initially suspected.
呋喃妥因(NIT)是治疗尿路感染常用的抗生素。尽管耐受性良好,但NIT并非没有潜在不良反应。本病例报告详细描述了一名接受氯氮平治疗的患者可能由NIT引起的药物热。一名61岁患有难治性精神分裂症的女性因妄想和幻听入住精神科病房,住院第1天开始使用氯氮平。由于幻觉和焦虑加重,入院8天后开始使用NIT进行抗生素治疗,推测用于治疗尿路感染。从住院第9天开始观察到发热发作,引发了对可能的抗精神病药物恶性综合征(NMS)的担忧,这导致停用氯氮平。患者共接受了3剂NIT,持续发热,直至住院第10天停药。未出现进一步并发症,住院第13天安全恢复使用氯氮平。尽管医学文献中对此描述较少,但此前已有NIT引起药物热的报道。对医学文献的回顾仅发现5篇先前发表的关于NIT引起药物热的文章,其中没有一篇提到对急性精神失代偿患者中断精神药物治疗的情况。本病例突出了在最初怀疑为NMS的情况下,对接受氯氮平治疗的患者中与NIT相关发热的鉴别诊断。